Proceeds to aid Australian charities and has donated US$29,000 to Camp Quality, a charity that supports children coping with cancer and their own families in Australia. In Australia, each day nearly three kids are identified as having cancer, and every full week 3 children will lose their battle with the condition. There are 15 currently, 000 children in Australia who are either recently diagnosed, in treatment or in remission from malignancy currently. The donation can help Camp Quality in its work to build resilience in the lives of kids living with cancer and their own families, through a combined mix of fun therapy, education and medical support.The efficacy of ponatinib shall be assessed compared to imatinib based on evaluation of the principal endpoint of main molecular response price at 12 months. ARIAD expects to complete patient enrollment in the trial by the final end of 2013. We have designed the EPIC trial with well-aligned and extensive input from key opinion leaders and regulatory authorities in the United States, Europe and Japan and anticipate strong interest from investigators and their sufferers, stated Harvey J. Berger, M.D., chairman and ceo of ARIAD. Dr. Berger added, The treatment of newly diagnosed CML sufferers has shifted in recent years to the use of second-generation BCR-ABL inhibitors.